The Infinium Global Research analyzes the Genome Engineering Market over the period of 2018 to 2024. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global genome engineering market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of genome engineering. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the genome engineering market during the period. The global genome engineering market is projected to grow at a CAGR of 11.80% over the forecast period of 2018-2024.
We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.
The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1327
A genome is the genetic material of an organism. Genome engineering or genome editing is a type of genetic engineering in which DNA is inserted, modified, deleted or replaced in the genome of the living organism. Several approaches to genome editing have been developed. A recent one is known as CRISPR-Cas9, which is short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. Genome editing is of huge interest in the prevention and treatment of human diseases. Currently, most research on genome engineering is done to understand diseases using cells and animal models.
Funding from the Government are the Primary Factors Responsible for Driving the Genome Engineering Market
Rising prevalence of infectious diseases and cancer, and availability of research grants & funding from the government are the primary factors responsible for driving the genome engineering market. Genome engineering is widely used in biotechnology and pharmaceutical companies, these companies are constantly indulged in research and development activities to prepare an antidote for the various infectious disease and cancer that helps to augment market growth. However lack of trained professionals and adverse public perception of genetic research is likely to be the restraint for the market growth.
The use of genetic engineering to treat increasingly prevalent chronic diseases and in preparing specialized or personalized medicine can create huge growth opportunities in near future for genome engineering market.
Get this Section as a Free Customization in the Report along with Discount on the Study: https://www.infiniumglobalresearch.com/reports/request-discount/1327
North America Region is Leading in the Genome Engineering Market
Geographically, North America is in the leading position among the other regions with a significant market share. U.S drives the North America genome engineering market, on account of factors such as development of gene therapy, increasing use of genetically modified crops and huge government funding for genome engineering research. Europe is expected to grow at the highest CAGR during the forecast period, 2018-2024.
Segments in the Genome Engineering Market
The report on global genome engineering market covers segments such as, technology, application and end-user. On the basis of technology the global genome engineering market is categorized into clustered regularly interspaced short palindromic repeats (CRISPR), transcription activator-like effector nuclease (TALEN), zinc finger nuclease (ZFN) and other technologies. On the basis of application the global genome engineering market is categorized into cell line engineering, animal genetic engineering, plant genome engineering and other applications. On the basis ofend-user, the global genome engineering market is categorized into biotechnology & pharmaceutical companies, academic & government research institutes and contract research organizations.
Key Players in the Genome Engineering Market
The report provides profiles of the companies in the global genome engineering market such as, Thermo Fisher Scientific, Merck, Horizon Discovery Group, Genscript, Sangamo Biosciences, Integrated DNA Technologies, Lonza, New England Biolabs, Origene Technologies and Transposagen Biopharmaceuticals.
Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-genome-engineering-market
Reasons to Buy this Report:
- Comprehensive analysis of global as well as regional markets of the genome engineering.
- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
- Infinium Global Research– Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.